Lupus News

Rheumatologists should use the standard of care alone rather than using additional immunosuppressants in adult patients with systemic lupus erythematosus with musculoskeletal manifestations, according to recommendations published in the Annals of the Rheumatic Diseases that were developed specifically for Latin American patients with lupus.

Approximately 47% of female patients in the United Kingdom who are prescribed hydroxychloroquine are given excess doses, based on ideal-body-weight dosing, according to findings published in Arthritis Research & Therapy.

Healio Rheumatology is proud to announce the launch of Rheuminations, a podcast series hosted by Adam Brown, MD, focusing on medical mysteries and other ripping yarns of the immune system gone awry.

Erythrocyte-bound C4d, a biomarker for systemic lupus erythematosus patented by Exagen Diagnostics, is useful in monitoring disease activity in patients with the condition, according to findings published in Lupus Science and Medicine.

Among rheumatologists, nephrologists and neurologists who issued more than 10 prescriptions for corticotropin in 2015, 88% received payments from its manufacturer — with more than 20% receiving more than $10,000 — despite the drug’s considerable cost and the dearth of evidence in support of its use, according to findings published in JAMA Network Open.

AMSTERDAM — IV doses of golimumab resulted in clinically meaningful improvements in skin psoriasis among patients with psoriatic arthritis as early as week 14, regardless of methotrexate use and nail symptoms, according to findings presented at the EULAR Annual Congress.

AMSTERDAM — Among patients with systemic lupus erythematosus who are receiving standard background therapy, additional treatment with daily, 4-mg doses of baricitinib was associated with significant clinical improvements compared to placebo, according to findings presented at the EULAR Annual Congress.

AMSTERDAM — Most young women with systemic lupus erythematosus can now carry out one or more pregnancies due to recent improvements in prevention, early diagnosis and the treatment of complications, according to findings presented at the EULAR Annual Congress.

The risk for autoimmune disease among teenage girls does not increase after they receive the quadrivalent HPV vaccine, according to findings published in the Canadian Medical Association Journal.

DESTIN, Fla. — Although the incidence of rheumatologic adverse effects associated with immune checkpoint inhibitors is expected to grow with their increased use, these effects remain poorly studied in random clinical trials, according to findings presented at the 2018 Congress of Clinical Rheumatology.